Company intelligence / Profile preview

Cation Pharma

Surat, Gujarat, India

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Cation Pharma is an Indian pharmaceutical company specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates, with a particular focus on complex peptides, corticosteroids, and oncology products.

Therapeutic areas: ImmunologyWomen's HealthCardiovascularEndocrinologyDermatologyOncology
Modalities: Small moleculePeptides
Industry: Contract Manufacturing Organization

Partnerships

Atmiya Exim House

Beyond the preview

Go deeper on Cation Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cation Pharma.

Explore the full profile